EUVIMEDEUVIMED entdecken
Crossref

Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition

Linda D Bosserman iD, Don S Dizon iD

Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1665-1669

DOI: 10.1200/jco-25-03121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Linda D Bosserman und 1 weiteren Autor:innen. Beteiligte Einrichtung: City of Hope, Duarte, CA. Die Arbeit nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • City of Hope, Duarte, CA.
  • Tufts Medicine, Tufts Medical Center, and Tufts University School of Medicine, Boston, MA.

ORCID-Profile: Linda D Bosserman, Don S Dizon

Zitieren

APA

Bosserman, L. D., & Dizon, D. S. (2026). Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition. Journal of Clinical Oncology, 44(18), 1665-1669. https://doi.org/10.1200/jco-25-03121

Vancouver

Bosserman LD, Dizon DS. Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition. Journal of Clinical Oncology. 2026;44(18):1665-1669. doi:10.1200/jco-25-03121

BibTeX
@article{Bosserman2026,
  author = {Bosserman, Linda D and Dizon, Don S},
  title = {Menopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibition},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {18},
  pages = {1665--1669},
  doi = {10.1200/jco-25-03121}
}
Kostenlos starten →